These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clarifying the role of incretin-based therapies in the treatment of type 2 diabetes mellitus. Campbell RK Clin Ther; 2011 May; 33(5):511-27. PubMed ID: 21665040 [TBL] [Abstract][Full Text] [Related]
3. Differentiating among incretin therapies: a multiple-target approach to type 2 diabetes. Cornell S J Clin Pharm Ther; 2012 Oct; 37(5):510-24. PubMed ID: 22436069 [TBL] [Abstract][Full Text] [Related]
4. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential. Østoft SH Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089 [TBL] [Abstract][Full Text] [Related]
5. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors. Neumiller JJ J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S16-29. PubMed ID: 19801361 [TBL] [Abstract][Full Text] [Related]
6. The incretin system and its role in type 2 diabetes mellitus. Holst JJ; Vilsbøll T; Deacon CF Mol Cell Endocrinol; 2009 Jan; 297(1-2):127-36. PubMed ID: 18786605 [TBL] [Abstract][Full Text] [Related]
7. Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes. Farngren J; Ahrén B Metabolism; 2019 Oct; 99():25-31. PubMed ID: 31279738 [TBL] [Abstract][Full Text] [Related]
9. The incretin effect in critically ill patients: a case-control study. Nielsen ST; Janum S; Krogh-Madsen R; Solomon TP; Møller K Crit Care; 2015 Nov; 19():402. PubMed ID: 26567860 [TBL] [Abstract][Full Text] [Related]
10. Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs. Deacon CF; Wamberg S; Bie P; Hughes TE; Holst JJ J Endocrinol; 2002 Feb; 172(2):355-62. PubMed ID: 11834453 [TBL] [Abstract][Full Text] [Related]
11. Incretin Physiology and Pharmacology in the Intensive Care Unit. Plummer MP; Hermanides J; Deane AM Crit Care Clin; 2019 Apr; 35(2):341-355. PubMed ID: 30784614 [TBL] [Abstract][Full Text] [Related]
12. The entero-insular axis: implications for human metabolism. Ranganath LR Clin Chem Lab Med; 2008; 46(1):43-56. PubMed ID: 18020966 [TBL] [Abstract][Full Text] [Related]
13. Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis. Deacon CF; Mannucci E; Ahrén B Diabetes Obes Metab; 2012 Aug; 14(8):762-7. PubMed ID: 22471248 [TBL] [Abstract][Full Text] [Related]
14. Incretin hormones: Their role in health and disease. Nauck MA; Meier JJ Diabetes Obes Metab; 2018 Feb; 20 Suppl 1():5-21. PubMed ID: 29364588 [TBL] [Abstract][Full Text] [Related]
15. The pharmacologic basis for clinical differences among GLP-1 receptor agonists and DPP-4 inhibitors. Morales J Postgrad Med; 2011 Nov; 123(6):189-201. PubMed ID: 22104467 [TBL] [Abstract][Full Text] [Related]
16. Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes. Herman GA; Bergman A; Stevens C; Kotey P; Yi B; Zhao P; Dietrich B; Golor G; Schrodter A; Keymeulen B; Lasseter KC; Kipnes MS; Snyder K; Hilliard D; Tanen M; Cilissen C; De Smet M; de Lepeleire I; Van Dyck K; Wang AQ; Zeng W; Davies MJ; Tanaka W; Holst JJ; Deacon CF; Gottesdiener KM; Wagner JA J Clin Endocrinol Metab; 2006 Nov; 91(11):4612-9. PubMed ID: 16912128 [TBL] [Abstract][Full Text] [Related]
17. Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications. Nauck MA Am J Med; 2011 Jan; 124(1 Suppl):S3-18. PubMed ID: 21194578 [TBL] [Abstract][Full Text] [Related]
18. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'. Skow MA; Bergmann NC; Knop FK Diabetes Obes Metab; 2016 Sep; 18(9):847-54. PubMed ID: 27160961 [TBL] [Abstract][Full Text] [Related]